c‐met tyrosine kinase receptor expression is associated with abnormal β‐catenin expression and favourable prognostic factors in invasive breast carcinoma

Abstract

Receptor-type tyrosine kinases are important in cell signal transduction and proliferation. Abnormal expression of tyrosine kinases often leads to malignant transformation. c-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF). In this study, we have evaluated c-met expression in 69 invasive breast carcinomas and statistically analysed this expression with known clinicopathological prognostic parameters and patients' survival. We also studied for the first time c-met expression in association with E-cadherin and β-catenin expression. Immunohistochemistry (ABC-HRP method) was peformed for the detection of c-met, E-cadherin and β-catenin. c-met immunoreactivity was observed in 58% of cases and was associated with the lobular type of breast carcinomas (P = 0.012), low histological grade ductal carcinomas (P = 0.05), favourable prognostic and predictive factors such as oestrogen and progesterone receptor immunohistochemical expression and negative c-erbB-2 expression (P = 0.05, P = 0.014 and P = 0.03, respectively). c-met immunoreactivity did not correlate with lymph node status, tumour size and stage of the disease. Cox's proportional hazard regression model demonstrated that tumours with positive c-met immunoreactivity correlated significantly with favourable patients' survival (P = 0.028). When c-met staining was compared with E-cadherin and β-catenin expression, a statistical significant correlation was established between c-met immunoreactivity and abnormal β-catenin expression (P = 0.025) suggesting possible involvement of c-met in the downregulation of the E-cadherin–catenin complex, possibly through tyrosine phosphorylation of β-catenin. c-met immunohistochemical expression seems to be associated with abnormal β-catenin expression, good prognostic and predictive factors and favourable outcome in breast cancer patients.